TOI

NASDAQ · Health Care

Oncology Institute Inc/The

Small-Cap Stocks Stocks Under $10 Healthcare Stocks

$5.48

+0.05 (+0.92%)

As of Jul 4, 2:06 AM ET ·

TOI News2 articles

GSK Acquires Nuvalent for $10.6B in Oncology Push Ahead of HIV Patent Cliff

GSK buys Nuvalent for $10.6B, paying a 40% premium, to strengthen its oncology portfolio and offset upcoming HIV drug patent losses.

Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal

French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.